Archived Event
The Alliance Advancement Series
Presented on: Tuesday, July 14, 2020
The ongoing disparity between the number of candidates on the national waitlist and the number of organs being transplanted continues to be a critical issue for the transplant community. This has resulted in innovative organ offer approaches and practices to expand the donor pool through inclusion of organs that would otherwise be discarded. This webinar will focus on the use of donors identified with a transmissible infection specifically, HIV and Hep C positive organs.
At the end of the webinar, participants should be able to:
- Describe the impact of utilizing HIV positive donors to improve organ utilization and expand the donor pool.
- Discuss the implications of utilizing HIV positive donors in living donation.
- Identify next steps for HIV donors with respect to future practices and innovative approaches.
- Distinguish the different types of Hepatitis C organ offers.
- Explain the impact on waitlist time and transplant rate for programs who have started taking Hep C NAT positive organs for NAT negative recipients.
- Outline the financial considerations for accepting Hep C NAT positive organ for NAT negative recipients.
Members of the donation and transplantation community serving diverse populations to include administrators, coordinators, physicians, nurses, surgeons, managers, quality improvement specialists, social workers, and other donation and transplantation center professionals and their colleagues.
Continuing Education Credits
Continuing Education credits are no longer available for this learning opportunity.